Minimal residual disease in gastrointestinal tumors: Tumor cell detection in bone marrow, blood and lymph nodes;Minimale residuale tumorerkrankung bei gastrointestinalen tumoren: Tumorzellnachweis in knochenmark, blut und lymphknoten

Acta Medica Austriaca

Volumn 29, Issue SUPPL. 59, 2002, Pages 42-53

  Rosenberg, R ^a   Nekarda, H ^a   Thorban, S ^a   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Blood; Bone marrow; Disseminated tumor cells; Gastrointestinal carcinoma; Lymph nodes; Micrometastases; Minimal residual disease; Prognosis

Indexed keywords

ARTICLE; BLOOD; BONE MARROW; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; DISSEMINATED CANCER; GASTROINTESTINAL TUMOR; HUMAN; LYMPH NODE; METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RECURRENT DISEASE; TUMOR CELL;

BONE MARROW; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM, RESIDUAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036957981     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Adell G, Boeryd B, Franlund B. Sjödahl R, Hakansson L: Occurence and Prognostic Importance of Micrometastases in Regional Lymph Nodes in Duke B Colorectal Carcinoma: An Immunohistochemical Study. Eur J Surg 1996;162:637-642.
2. Aihara T, Fujiwara Y. Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y. Tomita N, Sakon M, Shiozaki H, Monden M: Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Letters 2000;150:79-84.
3. Allgayer H, Heiss MM, Riesenberg R, Grützner KU, Tarabichi A, Babic R, Schildberg FW: Urokinase Plasminogen Activator Receptor (uPA-R): One Potential Characteristic of Metastatic Phenotypes in Minimal Residual Tumor Disease. Cancer Res 1997;57:1394-1399.
4. Ando N, Nakao A, Nomoto S, Takeda S, Kaneko T, Kurokawa T, Nonami T, Takagi H: Detection of Mutant K-ras in Dissected Paraaortic Lymph Nodes of Patients with Pancreatic Adenocarcinoma. Pancreas 1997;15:374-378.
5. Bessa X, Elizalde I, Boix L, Pinol V, Lacy AM, Salo J, Pique JM, Castells A: Lack of prognostic Influence of Circulating Tumor Cells in Peripheral Blood of Patients With Colorectal Cancer. Gastroenterology 2001;120:1084-1092.
6. Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B: Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 1998;185:427-434.
7. Bustin SA, Gyselman VG, Williams NS, Dorudi S: Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999;79:1813-1820.
8. Cai J, Ikeguchi M, Maeta M, Kaibara N: Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 1999;126:32-39.
9. Castells A, Boix L, Bessa X, Gargallo L, Pique JM: Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998;78:1368-1372.
10. Chausovsky G, Luchansky M, Figer A, Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S, Klein A: Expression of cytokeratin 20 in the Blood of Patients with Disseminated Carcinoma of the Pancreas, Colon, Stomach, and Lung. Cancer 1999;86:2398-2405.
11. Clarke G. Ryan E, O'Keane JC, Crowe J, MacMathuna P: The detection of cytokeratins in lymph nodes of Dukes's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000;12:549-552.
12. Cutait R, Venancio A, Lopes L, Cutait D, Borges J, Singer J, da Silva J, Goffi F: Restaging of Colorectal Cancer Based on the Identification of Lymph Node Micrometastases Through Immunoperoxidase Staining of CEA and Cytokeratins. Dis Colon Rectum 1991;34:917-920.
13. Davidson B, Smas V, Styles J, Deane C, Boulos P: Detection of Occult Metastases in Patients with Colorectal Carcinoma. Cancer 1990;65:967-970.
14. Demeure MJ, Doffek KM, Komorowski RA., Redlich PN, Zhu Y-R, Erickson BA, Ritch PS, Pitt HA, Wilson SD: Molecular metastases in stage I Pancreatic cancer: Improved survival with adjuvant chemoradiation. Surgery 1998;124:663-669.
15. Fujita S, Kudo N, Akasu T, Moriya Y: Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis 2001;16:141-146.
16. Funaki NO, Tanaka J. Hosotani R, Kogire M, Suwa H, Imamura M: Quantitative Analysis of Carcinoembryonic Antigen Messenger RNA in Peripheral Venous Blood and Portal Blood of Patients with Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 1998;4:855-860.
17. Funaki NO, Tanaka J, Imamura M: Quantitative Analysis of Alpha-Fetoprotein mRNA in Circulating Peripheral Blood of Patients with Hepatocellular and Alpha-fetoprotein-Producing Gastric Carcinomas. Life Sci 1998;62:1972-1984.
18. Funaki NO, Tanaka J, Kasamatsu T, Ohshio G, Hosotani R, Okino T, Imamura M: Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients. Life Sci 1996;59:2187-2199.
19. Funaki N.O., Tanaka J., Ohshio G., Onodera H., Maetani S., Imamura M: Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer 1998;77:1327-1332.
20. Funke I, Fries S, Rolle M, Heiss MM, Untch M, Bohmert H, Schildberg W, Jauch KW: Comparative Analysis of bone marrow micrometastases in breast and gastric cancer. Int J Cancer 1996;65:755-761.
21. Funke I, Schraut W: Meta-Analysis of Studies on Bone Marrow Micrometastases: An Independent Prognostic Impact Remains to be Substantiated. J Clin Oncol 1998;16:557-566.
22. Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S: Spread of colorectal cancer micrometasases in regional lymph nodes by reverse transcriptase-potymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. Surg Oncol 1998;68:34-40.
23. Gauthier LR, Granotier C, Soria J-C, Faivre S, Boige V. Raymond E, Boussin FD: Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 2001;84:631-635.
24. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M: Specific Detection of Carcinoembryonic Antigen - Expressing Tumor Cells in Bone Marrow Aspirates by Polymerase Chain. Reaction J Clin Oncol 1994;12:725-729.
25. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Phelps R, Nekarda H, Siewert JR. Neue Methode der Dichtegradienten-Zentrifugation zur Anreicherung disseminierter Tumorzellen in peripherem Blur yon Patienten mit gastrointestinalen Karzinomen. In: Btihren V, Bauer H, Metak G (eds): Wissenschaftliche Referate. 78. Tagung der Vereinigung der Bayerischen Chirurgen. München, Hieronymus Verlag, 2001, pp 23.
26. Glickman J, Torres C, Wang H, Turner J, Shahsafaei A, Richards W, Sugarbaker D, Odze R: The Prognostic Significance of Lymph Node Micrometastasis in Patients with Esophageal Carcinoma. Cancer 1999;85:769-778.
27. Greenson JK, Isenhart CE, Rice R, Majzisik C, Houchens D, Martin EW: Identification of occult micrometastases in pericolic lymph nodes of Dukes B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-569.
28. Gunn J, McCall JL, Yun K, Wright PA: Detection of Micrometastases in colorectal cancer pateints by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996;75:611-616.
29. Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M: No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery 1999;125:369-374.
30. Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW. Schildberg FW: Individual development and oPA-recepror expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1995;1:1035-1039.
31. Heiss MM, Allgayer H, Gruetzner KU, Babic R, Jauch KW, Schildberg FW: Clinical Value of Extended Biologic Staging by Bone Marrow Micrometastases and Tumor-Associated Proteases in Gastric Cancer. Ann Surg 1997;226:736-745.
32. Hermanek P: Disseminated Tumor Cells versus Micrometastasis: Definitions and Problems. Anticancer Research 1999;19:2771-2774.
33. Hermanek P, Hutter R, Sobin L, Wittekind C: Classification of Isolated Tumor Cells and Micrometastasis. Cancer 1999;86:2668-2673.
34. Hosch SB, Knoefel WT, Metz S, Stoecklein N, Niendorf A, Broelsch CE, Izbicki JR: Early Lymphatic Tumor Cell Dissemination in Pancreatic Cancer: Frequency and Prognostic Significance. Pancreas 1997;15:154-159.
35. Iinuma H, Okinaga K, Adachi M, Suda K, Sekine T, Sakagawa K, Baba Y, Tamura J, Kumagai H, Ida A: Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer 2000;89:337-344.
36. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S: Immunohistochemical Evaluation of Lymph Node Micromestases from Gastric Carcinomas. Cancer 19 997;79:1069-1076.
37. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K: Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected oesophageal cancer. N Engl J Med 1997;337:188-1194.
38. Jauch K-W, Heiss MM, Gruetzner U, Funke I, Pantel K, Babic R, Eissner H-J, Riethmueller G, Schildberg F-W: Prognostic Significance of Bone Marrow Micrometastases in Patients with Gastric Cancer. J Clin Oncol 1996;14:1810-1817.
39. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M: The prognostic significance of immunohistochemically detected colorectal carcinoma. J Pathol 1994;172:183-187.
40. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener C, Schreiber H-W, Kalthoff H: Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pacreatic cancer patients. Int J Cancer 1994;57:330-335.
41. Juhl H, Kalthoff H, Krüger U, Schott A, Schreiber H-W, Henne-Bruns D, Kremer B: Immuncytologischer Nachweis disseminierter Tumorzellen in der Bauchhöhle und im Knochenmark von Pankreaskarzinom-Patienten. Chirurg 1994;65:1111-1115.
42. Kienle P, Weitz J, Klaes R, Koch M, Benner A, Lehnert T, Herfarth C, v Knebel Doeberitz M: Detection of Isolated Disseminated Tumor Cells in Bone Marrow and Blood Samples of Patients With Hepatocellular Carcinoma. Arch Surg 2000;135:213-218.
43. Kijima F, Natsugoe S, Takao S, Aridmoe K, Baba M, Yoshifumi M, Eizuru Y, Aikou T: Detection and Clinical Significance of Lymph Node Micrometastasis Determined by Reverse Transcription-Polymerase Chain Reaction in Patients with Esophageal Carcinoma. Oncology 2000;58:38-44.
44. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmueller G: Comparative genomic hybridzation, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999;96:4494-4499.
45. Koch M, Weitz J, Kienle P, Benner A, Willeke F, Lehnert T, Herfarth C, v Knebel Doeberitz M: Comparative Analysis of Tumor Cell Dissemination in Mesenteric, Central, and Peripheral Venous Blood in Patients With Colorectal Cancer. Arch Surg 2001;136:85-89.
46. Komukai S, Nishimaki T, Watanabe H, Ajioka Y, Suzuki T. Hatakeyama K: Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery 2000, 127:40-46.
47. Liefers GJ, Cleton-Janson AM, Van De Velde JH, Hermans J, Van Krieken JHJM, Cornelisse C J, Tollenaar RAEM: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-228.
48. Lindemann F, Sclimok G, Dischedl P, Witte J, Riethmueller G: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer cells. Lancet 1992;340:685-689.
49. Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, Yousem SA, Siegfreid JM: Detection of Micrometastases in Histologically Negative Lymph Nodes in Esophageal Cancer. Ann Thorac Surg 1998;66:1715-1718.
50. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y. Kohnoe S, Sugimachi K: Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
51. Maehara Y, Hasuda S, Abe T, Oki E, Kakeji Y, Ohno S, Sugimachi K: Tumor Angiogenesis and Micrometastasis in Bone Marrow of Patients with Early Gastric Cancer. Clin Cancer Res 1998;4:2129-2134.
52. Maehara Y, Yamamoto M, Baba H, Kusumoto T, Ohno S, Ichiyoshi Y, Sugimachi K: Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer. Br J Cancer 1996;73:83-87.
53. Miyake Y, Fujiwara Y, Ohue M, Yamamoto H, Sugita Y, Tomita N, Sekimoto M, Shiozaki H, Monden M: Quantification of micrometastases in lymph nodes of colorectal cancer using real-time flourescence polymerase chain reaction. Int J Oncol 2000;16:289-293.
54. Miyake Y, Yamamoto H, Fujiwara Y, Ohue M, Sugita Y, Tomita N, Sekimoto M, Matsuura N, Shiozaki H, Monden M: Extensive Micrometastases to Lymph Nodes as a Marker for Rapid Recurrence of Colorectal Cancer: A Study of Lymphatic Mapping. Clin Cancer Res 2001;7:1350-1357.
55. Miyazono F. Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, Hokita S, Baba M, Eizuru Y, Aikou T: Surgical Maneuvers Enhance Molecular detection of Circulating Tumor Cells Gastric Cancer Surgery. Ann Surg 2001;233:189-194.
56. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T: Clinical Significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-Polymerase Chain Reaction in Patients with Gastrointestinal or Breast Carcinomas. J Clin Oncol 1998;16:128-132.
57. Mori M, Mimori K, Inoue H, Barnard G, Tsuji K, Nanbara S, Ueo H, Akiyoshi T: Detection of Cancer Micrometastases in Lymph Nodes by Reverse Transcriptase-Polymerase Chain Reaction. Cancer Res 1995;55:3417-3420.
58. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akiyoshi T: Molecular Detection of Circulating Solid Carcinoma Cells in the Peripheral Blood: The Concept of Early Systemic Disease. Int J Cancer 1996;68:739-743.
59. Mueller JD, Stein HJ, Oyang T Natsugoe S, Feith M, Werner M, Siewert JR: Frequency and Clinical Impact of Lymph Node Micrometastasis and Tumor cell Microinvovement in Patients with Adenocarcinoma of the Esophagogastric Junction. Cancer 2000;89:1874-1882.
60. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, Baba M, Takao S, Aikou T: Detection and Prediction of Micrometastasis in the Lymph Nodes of Patients With pN0 Gastric Cancer. Ann Surg Oncol 2000;8:158-162.
61. Nakamori S, Kameyama M, Furukawa H, Takeda O, Sugai S, Imaoka S, Nakamura Y: Genetic Detection of Colorectal Cancer Cells in Circulation and Lymph Nodes. Dis Colon Rectum 1997;40 (Suppl):29-36.
62. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S: Clinical Implications of Lymph Node Micrometastases in Patients with Colorectal Cancers. Oncology 1999;57:276-280.
63. Natsugoe S, Mueller J, Stein HJ, Feith M, Höfler H, Siewert JR: Micrometastasis and Tumor Cell Microinvolvement of Lymph Nodes from Esophageal Squamous Cell Carcinoma. Cancer 1998;83:858-866.
64. Nicholson AG, Marks CG, Cook MG: Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative coloectal carcinomas. Gut 1994;35:1447-1448.
65. Nishida S, Kitamura K, Ichikawa D, Koike H, Tani N, Yamagishi H: Molecular Detection of Disseminated Cancer Cells in the Peripjeral Blood of Patients with Gastric Cancer. Anticancer Res 2000;20:2155-2160.
66. Noguchi S, Hiratsuka M, Furukawa H, Aihara T, Kasugai T, Tamura S, Imaoka S, Koyama H, Iwanaga T: Detection of Gastric Cancer Micrometastases in Lymph Nodes by Amplification of Keratin 19 mRNA with Reverse Transcriptase-Polymerase Chain Reaction Jpn J Cancer Res 1996;87:650-654.
67. Öberg A, Stenling R, Tavelin B, Lindmark G: Are lymph node micrometastases of any clinical significance in Dukes Stage A and B colorectal cancer? Dis Colon rectum 1998;41:1244-1249.
68. Okada Y, Fujiwara Y, Yamamoto H, Sugita Y, Yasuda T, Doki Y, Tamura S. Yano M, Shiozaki H, Matsuura N, Monden M: Genetic Detection of Lymph Node Micrometastases in Patients with Gastric Carcinoma by Multiple-Marker Reverse Transcriptase-Polymerase Chain Reaction Assay. Cancer 2001;92:2056-2064.
69. O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F: Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 1997;40:512-515.
70. O'Sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, Walsh T, Collins JK, Shanahan F: Micrometastases in oesophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999;116:543-548.
71. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Izhicki JR, Riethmtiller G: Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone Marrow. J Hematother 1994;3:165-173.
72. Piva MG, Navaglia F, Basso, Fogar P, Roveroni G, Gallo N, Zambon C-F, Pedrazzoli S, Plehani M: CEA mRNA Identification in Peripheral Blood Is Feasible for Colorectal, But Not for Gastric or Pancreatic Cancer Staging. Oncology 2000;59:323-328.
73. Ridwelski K, Meyer F, Fahlke J, Kasper U, Roessner A, Lippert H: Stellenwert con Cytokeratin- und CA 19-9-Antigen im immunhistologischen Nachweis disseminierter Tumorzellen in Lymphknoten beim Pankreaskarzinom. Chiurg 2001;72:920-926.
74. Roder JD, Thorban S, Pantel K, Siewert JR: Micrometastases in bone marrow: prognostic indicators for pancreatic cancer. World J Surg 1999;23:888-891.
75. Rosenberg R, Hoos A, Mueller J. Nekarda H: Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 2000;83:1323-1329.
76. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H, Siewert JR: The Prognostic Significance of Cytokeratin-20 RT-PCR in Lymph Nodes of Node Negative (pN0) Colorectal Cancer Patients. J Clin Oncol 2002;20:1049-1055.
77. Rosenberg R, Gertzen R, Friederichs J, Fuehrer K, Dahm M, Phelps R, Thorban S, Nekarda H, Siewert JR: Comparison of two density gradient centrifugation Systems for the Enrichment of disseminated Tumor cells in blood. Cytometry 2002, in press.
78. Sanchez-Cespedes M, Esteller M, Hibi K, Cope F, Westra W, Piantadosi S, Herman J, Jen J, Sidransky D: Molecular Detection of Neoplastic Cells in Lymph Nodes of Metastatic Colorectal Cancer Patients predicts Recurrence. Clin Cancer Res 1999;5:2450-2454.
79. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K: Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32:758-764.
80. Schlimok G, Funke I, Holzmann B, Göttlinger G, Schmidt G, Häuser H, Swierkot S, Wamecke HH, Scheider B, Koprowski H, Riethmüller G: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17 1A monoclonal antibodies. Proc Natl Acad Sci 1987;84:8672-8676.
81. Schlimok G, Funke I, Pantel K, Strobel S, Lindemann F, Witte J, Riethmueller G: Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991;27:1461-1465.
82. Soeth E, Vogel I, Roder C, Juhl H, Marxen J, Kruger U, Henne-Bruns D, Kremer B, Kalthoff H: Comparative analysis of bone marrow and venous blood isolated from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106-3110.
83. Soeth E, Röder C, Juhl H, Krüger U, Kremer B, Kalthoff H: The Detection of disseminated tumor cells in bone marrow from colorectal cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996;69:278-282.
84. Tamagawa E, Ueda M, Takahashi S, Sugano K, Uematsu S, Mukai M, Ogata Y, Kitajima M: Pancreatic Lymph Nodal and Plexus Micrometastases Detected by Enriched Polymerase Chain Reaction and Nonradioisotopic Single-Strand Confirmation Polymorphism Analysis: A New Predictive Factor for Recurrent Pancreatic Carcinoma. Clin Cancer Res 1997;3:2143-2149.
85. Taniguchi T, Makino M, Suzuki K, Kaibara N: Prognostic Significance of reverse Transcriptase Polymerase Chain Reaction Measurement of carcinoembryonic Antigen mRNA Levels in Tumor Drainage Blood and peripheral Blood of Patients with Colorectal Carcinoma. Cancer 2000;89:970-976.
86. Thorban S, Rosenberg R, Busch R, Roder J: Epithelial cells in bone marrow of esophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 2000;83:35-39.
87. Thorban S, Roder JD, Nekarda H, Funk A, Siewert JR, Pantel K: Immunocytochemical Detection of Disseminated Tumor Cells in the Bone Marrow of Patients With Esophageal Carcinoma. J Ntl Cancer Inst 1996;88:1222-1227.
88. Thorban S, Roder JD, Pantel K, Siewert JR: Epithelial Tumour Cells in Bone Marrow of Patients with Pancreatic Carcinoma Detected by Immunocytochemical Staining. Eur J Cancer 1996;32:363-365.
89. Tschmelitsch J, Klimstra DS, Cohen AM: Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000;7:601-608.
90. Vogel I, Kruger U, Marxen J, Soeth E, Kalthoff H, Henne-Bruns D, Kremer B, Juhl H: Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res 1999;5:593-599.
91. Weitz J, Kienle P, Magener A, Koch M, Schrödel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth C, v. Knebel Doeberitz M: Detection of Disseminated Colorectal Cancer Cells in Lymph Nodes, Blood and Bone Marrow. Clin Cancer Res 1999;5:1830-1836.
92. Weitz J, Koch M, Kienle P, Schrödel A, Willeke F, Benner A, Lehnert T, Herfarth C, v Knebel Doeberitz M: Detection of hematogenic Tumor Cell Dissemination in Patients Undergoing Resection of Liver Metastases of Colorectal Cancer. Ann Surg 2000;232:66-72.
93. Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, v Knebel Doeberitz M: Dissemination of Tumor Cells in Patients Undergoing Surgery for Colorectal Cancer. Clin Cancer Res 1998;4:343-348.
94. Wharton RQ, Jonas SK, Glover C, Khan ZA, Klokouzas A, Quinn H, Henry M, Allen-Mersh TG: Increased Detection of Circulating Tumor Cells in the Blood of Colorectal Carcinoma Patients Using Reverse Transcription-PCR Assays and Multiple Blood Samples. Clin Cancer Res 1999;5:4158-4163.
95. Wyld D, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J, Burchill SA: Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998; 79: 288-293
96. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S: Significant Detection of Circulating Cancer Cells in the Blood by Reverse Transcriptase-Polymerase Chain Reaction During Colorectal Cancer Resection. Ann Surg 2000;232:58-65.
97. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S: Pattern of Lymph Node Micrometastasis and Prognosis of Patients with Colorectal Cancer. Ann Surg Oncology 2001;8:300-304.
98. Yun K, Merrie AEH, Gunn J, Philips LV, McCall JL: Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-ras mutations. J Pathol 2000;191:21-26.